JP2011509926A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011509926A5 JP2011509926A5 JP2010538713A JP2010538713A JP2011509926A5 JP 2011509926 A5 JP2011509926 A5 JP 2011509926A5 JP 2010538713 A JP2010538713 A JP 2010538713A JP 2010538713 A JP2010538713 A JP 2010538713A JP 2011509926 A5 JP2011509926 A5 JP 2011509926A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- polypeptide
- modified polypeptide
- acid residues
- target
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 15
- 102000004196 processed proteins & peptides Human genes 0.000 claims 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims 15
- 238000000034 method Methods 0.000 claims 12
- 125000000539 amino acid group Chemical group 0.000 claims 11
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 3
- 230000002378 acidificating effect Effects 0.000 claims 3
- 235000003704 aspartic acid Nutrition 0.000 claims 3
- CKLJMWTZIZZHCS-REOHCLBHSA-N aspartic acid group Chemical group N[C@@H](CC(=O)O)C(=O)O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 3
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 3
- 238000002059 diagnostic imaging Methods 0.000 claims 3
- 235000013922 glutamic acid Nutrition 0.000 claims 3
- 239000004220 glutamic acid Substances 0.000 claims 3
- 239000012216 imaging agent Substances 0.000 claims 3
- 239000004475 Arginine Substances 0.000 claims 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims 2
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims 2
- 239000004472 Lysine Substances 0.000 claims 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims 2
- 238000003384 imaging method Methods 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims 1
- 125000000487 histidyl group Chemical group [H]N([H])C(C(=O)O*)C([H])([H])C1=C([H])N([H])C([H])=N1 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 238000011503 in vivo imaging Methods 0.000 claims 1
- 210000004185 liver Anatomy 0.000 claims 1
- 230000002285 radioactive effect Effects 0.000 claims 1
- 238000006467 substitution reaction Methods 0.000 claims 1
- 230000008685 targeting Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12/002,972 | 2007-12-19 | ||
| US12/002,972 US8937047B2 (en) | 2007-12-19 | 2007-12-19 | Biokinetics of fast-clearing polypeptides |
| PCT/EP2008/067774 WO2009077569A1 (en) | 2007-12-19 | 2008-12-17 | Biokinetics of fast-clearing polypeptides |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011509926A JP2011509926A (ja) | 2011-03-31 |
| JP2011509926A5 true JP2011509926A5 (cg-RX-API-DMAC7.html) | 2013-01-31 |
| JP5745275B2 JP5745275B2 (ja) | 2015-07-08 |
Family
ID=40591871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010538713A Active JP5745275B2 (ja) | 2007-12-19 | 2008-12-17 | 迅速クリアランスポリペプチドの生体内動態 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US8937047B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP2231706B3 (cg-RX-API-DMAC7.html) |
| JP (1) | JP5745275B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN101952314B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE529445T1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2375018T7 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2009077569A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9187535B2 (en) * | 2007-12-19 | 2015-11-17 | Affibody Ab | Polypeptide derived from protein A and able to bind PDGF |
| US8937047B2 (en) * | 2007-12-19 | 2015-01-20 | General Electric Company | Biokinetics of fast-clearing polypeptides |
| US8124725B2 (en) * | 2007-12-19 | 2012-02-28 | General Electric Company | PDGF-Rβ binders |
| EP2077272A1 (en) * | 2007-12-21 | 2009-07-08 | Affibody AB | Polypeptide libraries with a predetermined scaffold |
| EP2072525A1 (en) | 2007-12-21 | 2009-06-24 | Affibody AB | New polypeptides having affinity for HER2 |
| US20120165650A1 (en) | 2010-12-22 | 2012-06-28 | General Electric Company | Her2 binders |
| US10861978B2 (en) | 2012-04-02 | 2020-12-08 | Samsung Display Co., Ltd. | Display device |
| CN112870390B (zh) * | 2021-01-29 | 2022-04-22 | 四川大学华西医院 | 一种镓68标记的亲合体蛋白pet显像剂及应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5322678A (en) | 1988-02-17 | 1994-06-21 | Neorx Corporation | Alteration of pharmacokinetics of proteins by charge modification |
| US6673559B1 (en) | 1989-12-27 | 2004-01-06 | The Government Of The United States Of America As Represented By The Department Of Health And Human Services | Met proto-oncogene and a method for predicting breast cancer progression |
| US6271364B1 (en) | 1999-02-23 | 2001-08-07 | Amgen Inc. | Analogs of NT-3 |
| US6020163A (en) | 1997-08-06 | 2000-02-01 | Zymogenetics, Inc. | Lipocalin homolog |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| US7118915B2 (en) | 2001-09-27 | 2006-10-10 | Pieris Proteolab Ag | Muteins of apolipoprotein D |
| US20060008844A1 (en) | 2004-06-17 | 2006-01-12 | Avidia Research Institute | c-Met kinase binding proteins |
| EP3127921A1 (en) | 2007-09-26 | 2017-02-08 | Chugai Seiyaku Kabushiki Kaisha | Method of modifying isoelectric point of antibody via amino acid substition in cdr |
| KR20150126724A (ko) | 2007-09-28 | 2015-11-12 | 추가이 세이야쿠 가부시키가이샤 | 혈장 중 반응속도가 개선된 항-글리피칸-3 항체 |
| US8937047B2 (en) * | 2007-12-19 | 2015-01-20 | General Electric Company | Biokinetics of fast-clearing polypeptides |
| US8124725B2 (en) * | 2007-12-19 | 2012-02-28 | General Electric Company | PDGF-Rβ binders |
-
2007
- 2007-12-19 US US12/002,972 patent/US8937047B2/en active Active
-
2008
- 2008-12-17 ES ES08863248T patent/ES2375018T7/es active Active
- 2008-12-17 AT AT08863248T patent/ATE529445T1/de not_active IP Right Cessation
- 2008-12-17 CN CN200880127378.0A patent/CN101952314B/zh active Active
- 2008-12-17 JP JP2010538713A patent/JP5745275B2/ja active Active
- 2008-12-17 EP EP08863248A patent/EP2231706B3/en active Active
- 2008-12-17 WO PCT/EP2008/067774 patent/WO2009077569A1/en not_active Ceased